Cargando…
Sub-acute systemic erythropoietin administration reduces ischemic brain injury in an age-dependent manner
Stroke is associated with neuroinflammation, neuronal loss and blood-brain barrier (BBB) breakdown. Thus far, recombinant tissue-type plasminogen activator (rtPA), the only approved treatment for acute ischemic stroke, increases the risk of intracerebral hemorrhage and is poorly efficient in disaggr...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094944/ https://www.ncbi.nlm.nih.gov/pubmed/27248662 http://dx.doi.org/10.18632/oncotarget.9652 |